Skip to search formSkip to main contentSkip to account menu

bucolome

Known as: 1-cyclohexyl-5-butylbarbituric acid, 2,4,6(1H,3H,5H)-Pyrimidnetrione, 5-butyl-1-cyclohexyl- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
BACKGROUND Bucolome, a nonsteroidal antiinflammatory drug, enhances the effects of warfarin. In the present study, the effects of… 
2008
2008
Losartan, a selective angiotensin receptor antagonist, is mainly metabolized by CYP2C9 to an active carboxylic acid, E3174, which… 
2005
2005
To determine whether bucolome (5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine), a nonsteroidal anti-inflammatory agent… 
2001
2001
The objective of this study was to investigate the stereoselective influence of bucolome on the pharmacokinetics and… 
1999
1999
A uricosuric agent, bucolome, has been shown to intensify the anticoagulant effect of warfarin. The aims of the present study… 
1985
1985
A biliary metabolite of bucolome in rat was isolated and purified by column chromatography. The metabolite has been identified as… 
1982
1982
Abstract: Three forms of enolase isozymes (αα, αγ, and γγ), including nervous system‐specific forms, were measured in the… 
1978
1978
Effects of bucolome on congenitally jaundiced Gunn rats were examined. Plasma total bilirubin level fell immediately after a… 
1977
1977
Fifty preterm babies were randomly assigned to a group given oral bucolome (30 mg/kg per day for 5 days) and a control group… 
1977
1977
Choleresis induced by bucolome (BC) (1-cyclohexyl-5-n-butyl-2,4,6-trioxoperhydropyrimidine) was studied in male Wistar rats. [14C…